ArticleScience advances2024

HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.

Fanghui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.